LKB1 Inactivation Elicits a Redox Imbalance to Modulate Non-Small Cell Lung Cancer Plasticity and Therapeutic Response

Cancer Cell - United States
doi 10.1016/j.ccell.2015.04.001
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Elsevier BV

Related search

Hmgb1: A Potential Therapeutic Target for Non-Small Cell Lung Cancer

Lettters in Health & Biological Sciences
2016English

Non-Small Cell Lung Cancer: Therapeutic and Evolutionary Aspects in Cote D’Ivoire

Advances in Lung Cancer
2018English

WEE1 Kinase Inhibitor AZD1775 Has Preclinical Efficacy in LKB1-Deficient Non–Small Cell Lung Cancer

Cancer Research
Cancer ResearchOncology
2017English

Non-Small Cell Lung Cancer

English

Expanding Anaplastic Lymphoma Kinase Therapeutic Indication to Early Stage Non-Small Cell Lung Cancer

Translational Lung Cancer Research
Oncology
2019English

Cotargeting EGFR and Autophagy Signaling: A Novel Therapeutic Strategy for Non-Small-Cell Lung Cancer

Molecular and Clinical Oncology
Cancer ResearchOncology
2013English

OA01 LKB1 Pathway Variant TSC2 Rs30259 Predicts the Prognosis in Early Stage Non-Small Cell Lung Cancer

Journal of Thoracic Oncology
MedicineOncologyRespiratory MedicinePulmonary
2018English

Staging Non-Small Cell Lung Cancer

Cancer Imaging
Nuclear MedicineRadiologyUltrasound TechnologyOncologyRadiologicalImagingMedicine
2007English

Advanced Non-Small-Cell Lung Cancer in Elderly Patients: Patient Features and Therapeutic Management

BioMed Research International
ImmunologyMolecular BiologyBiochemistryMicrobiology MedicineGenetics
2018English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy